Drug recall · January 1, 2020
Estriol [ recall
Why: Subpotent Drug: Supplier indicated assay results did not meet specifications.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Estriol [(16a, 17B)-Estra-1,3,5(10)-triene-3,16,17-triol; Oestriol] Micronized, USP, CAS 50-27-1, packaged in a) 1 G glass bottles, b) 5 G glass bottles, c) 25 G glass bottles, d) 100 G glass bottles, e) 500 G glass bottles, and f) 1 KG plastic bottles, Rx Only, Spectrum Chemical Mfg Corp., Gardena, CA 90248.
- Lots / codes
Lot #s: 1HG0308, 1HH0630, 1HI0854, 4HL0005,4HL0036, 4IH0032, Exp. 04/16/2021
- Quantity
- 6.284 kg
- Company
- Spectrum Laboratory Products, Gardena, CA
- Distribution
- Nationwide in the USA and Canada
- Initiated
- December 11, 2019 · Voluntary: Firm initiated
- Classified
- December 23, 2019
- Reported
- January 1, 2020
- Ended
- August 17, 2023
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.